Compared with developed economies, health expenditure in China is not particularly high on a per capita basis or as a share of Gross Domestic Product (GDP). Similarly, pharmaceutical expenditure in comparative perspective is not particularly high on a per capita basis or as a percentage of GDP. China's exceptionally high rate of pharmaceutical expenditure has important implications for the future of a health care system that not only serves a rapidly...
Exibir mais
DETALHES
-
2010/06/01
-
Documento de Trabalho (Série Numerada)
-
58413
-
1
-
2010/12/14
-
Disclosed
-
Executive summary
-
payments for health services
DOWNLOADS
COMPLETAR RELATÓRIO
Versão oficial do documento (pode conter assinaturas, etc.)
-
Total Downloads** : 461
*A versão do texto é um OCR incorreto e está incluído unicamente em benefício de usuários com conectividade lenta.